CCL2 and COVID-19: An aggressive inflammatory response, accompanied by high levels of chemokines and cytokines, such as IL-2, IL-6, IL-7, IL-10, TNF-α, IFN-γ, IP10, and MCP1, was identified in patients with COVID-19 (13–15).